Acid reflux is one of the top three causes of chronic cough in adults, responsible for a substantial share of cases that persist for eight weeks or longer. Along with asthma and upper-airway cough syndrome (formerly called postnasal drip), reflux forms what researchers have called the “pathogenic triad” behind unexplained chronic cough. What makes reflux cough frustrating is that it often shows up without the classic burning sensation most people associate with heartburn, and standard acid-suppressing medications do not always resolve it. The reasons for that disconnect say a lot about how the cough actually develops and what it takes to treat it effectively.
How Reflux Triggers a Cough
There are two broad pathways by which stomach contents provoke coughing, and they can operate at the same time. The first is a nerve reflex. When acidic or otherwise irritating material enters the lower esophagus, it stimulates nerve fibers carried by the vagus nerve. Those fibers send signals that sensitize the cough reflex, making you more likely to cough in response to even mild irritants. Animal studies have confirmed that acid in the distal esophagus alone, without any material reaching the throat or lungs, is enough to trigger this reflex.1PubMed Central. Cough and gastroesophageal reflux: insights from animal models Acid is considered the single most important mediator in this reflex pathway, and the sensitization it causes can persist well beyond a single reflux episode.2PubMed Central. Acid-sensitive vagal sensory pathways and cough
The second pathway is direct irritation and microaspiration. Refluxed material can travel all the way up to the larynx, vocal cords, or even the lower airways, irritating tissue on contact. One study found that among patients with confirmed pathological reflux, over half tested positive for lipid-laden macrophages in fluid drawn from the lungs, a marker suggesting tiny amounts of stomach content had reached the airways. Only about five percent of patients without pathological reflux showed the same marker.3PubMed Central. The Role of Microaspiration in the Pathogenesis of Gastroesophageal Reflux-related Chronic Cough Research has also confirmed that reflux can irritate the upper respiratory tract without full aspiration, damaging the larynx even if material never makes it into the lungs.4The American Journal of Gastroenterology. Gastroesophageal reflux and chronic cough
What ties both pathways together is that the cough reflex becomes hypersensitive. Patients with chronic cough show heightened responses to irritants that barely bother healthy people. One study of over 200 patients found that roughly 40 percent exhibited abnormal cough sensitivity to at least one of two common chemical triggers, and the effect was more pronounced in women.5Respiratory Research. Heterogeneity of cough hypersensitivity mediated by TRPV1 and TRPA1 in patients with chronic refractory cough Once the cough reflex is wound up by reflux, ordinary things like cold air, talking, or laughing can set off a coughing fit that seems unrelated to your stomach.
Why You Can Have Reflux Cough Without Heartburn
Many people assume that if they do not feel a burning sensation behind the breastbone, acid reflux is not the problem. That assumption trips up patients and doctors alike. Reflux that reaches the throat and larynx, sometimes called laryngopharyngeal reflux, frequently produces no heartburn at all. The esophagus has some built-in defenses against acid, but the throat and vocal cords do not, so even small amounts of refluxate can cause hoarseness, throat clearing, a sensation of a lump in the throat, and chronic cough without triggering classic GERD symptoms. A multicenter study using combined pressure and pH monitoring found that a diagnosis of reflux-induced cough was made in about a quarter of patients with chronic unexplained cough, and those patients were only somewhat more likely to report typical reflux symptoms than those whose cough had nothing to do with reflux.6Diseases of the Esophagus. Ambulatory pH-impedance-pressure monitoring as a diagnostic tool for the reflux–cough syndrome
The disconnect between symptoms and reality is a major reason reflux cough goes unrecognized. If you wait for heartburn to appear before suspecting reflux, you will miss a large fraction of cases. Many patients spend months being treated for post-nasal drip or asthma before anyone considers the stomach.
Non-Acid Reflux Can Cause Coughing Too
Acid-suppressing drugs like proton pump inhibitors (PPIs) reduce the acidity of stomach contents, but they do not stop reflux from happening. Material still moves upward from the stomach; it just is not as acidic. For some patients, that weakly acidic or even non-acidic refluxate is enough to keep the cough going. Combined pH-impedance monitoring has made it possible to detect these episodes, revealing a subgroup of patients whose cough clearly correlates with reflux that standard pH testing would miss entirely.7PubMed Central. Weakly acidic reflux in patients with chronic unexplained cough during 24 hour pressure, pH, and impedance monitoring
In one study of patients already taking acid-suppressive therapy whose cough persisted, about a quarter had a positive association between their cough episodes and non-acid reflux events. Several of those patients eventually underwent anti-reflux surgery and became cough-free after stopping all medications.8Chest. Nonacid reflux in patients with chronic cough on acid-suppressive therapy The takeaway is that if PPIs are not resolving your cough, the problem is not necessarily that reflux has been ruled out. It may be that the type of reflux causing the cough is not the type PPIs are designed to treat.
How Reflux Cough Gets Diagnosed
Diagnosing reflux as the cause of a chronic cough is genuinely difficult. There is no single test that settles it. The approach is usually stepwise: a clinician considers your symptom profile, may try an empirical course of acid suppression, and if the picture remains unclear, moves on to more specialized testing.
The current gold-standard test is multichannel intraluminal impedance combined with pH monitoring (MII-pH). This technique tracks both acid and non-acid reflux events along the esophagus over a 24-hour period and can correlate those events with when you actually cough. One study found it had a sensitivity above 90 percent and an area under the curve of about 0.86 for identifying reflux-caused cough, outperforming standard pH monitoring alone.9PubMed Central. Diagnostic accuracy of multichannel intraluminal impedance-pH monitoring for gastroesophageal reflux-induced chronic cough When pressure sensors are added to the setup, clinicians can also distinguish reflux that triggers cough from cough that triggers reflux, an important distinction because the latter does happen and requires different thinking.10Diseases of the Esophagus. Ambulatory pH-impedance-pressure monitoring as a diagnostic tool for the reflux–cough syndrome
The catch is that these tests are invasive. You wear a thin catheter through your nose into your esophagus for a full day. Patients often do not tolerate it well, which limits how widely it is used in routine practice.11PubMed Central. GERD-related chronic cough: Possible mechanism, diagnosis and treatment Researchers have been looking for less invasive alternatives. A recent prospective study tested salivary pepsin concentration as a diagnostic marker and found it performed well, with an area under the curve of about 0.85 and sensitivity and specificity both above 80 percent. Pepsin testing was particularly useful for non-acidic reflux cough, where conventional questionnaire-based screening tools fell short.12PubMed Central. Diagnostic value of the pepsin concentration in saliva and induced sputum for gastroesophageal reflux-induced chronic cough: a prospective clinical study That test is not yet in widespread clinical use, but it represents a less burdensome option on the horizon.
High-resolution manometry, which maps pressure patterns along the esophagus during swallowing, has also revealed something interesting. Patients with chronic cough who show long breaks in the wave of esophageal squeezing that normally clears the esophagus tend to respond poorly to standard anti-reflux treatment. In one study, the presence of these breaks predicted suboptimal symptom improvement.13PubMed Central. Chronic Cough Is Associated With Long Breaks in Esophageal Peristaltic Integrity on High-resolution Manometry That is the kind of information that could eventually help clinicians decide which patients need something beyond PPIs from the start.
What Works for Treatment and What Does Not
Treatment usually begins with lifestyle changes and acid suppression, then escalates if those fail. The evidence for each step is more mixed than you might expect.
PPIs are the first-line medication prescribed for reflux cough, and older review articles suggested using double-dose PPIs for at least two to three months.14PubMed. The role of proton pump inhibitors in the management of gastroesophageal reflux disease-related asthma and chronic cough But the more carefully controlled the study, the less impressive the results look. A randomized, double-blind, placebo-controlled trial of high-dose PPIs found no statistically significant improvement in cough compared to placebo. Patients in both groups improved, suggesting a strong placebo effect, but the PPI group did not improve more.15PubMed Central. High-Dose Acid Suppression for Chronic Cough: A Randomized, Double-Blind, Placebo-Controlled Trial A major expert panel report from the American College of Chest Physicians came to a similar conclusion: PPIs showed no benefit when used in isolation, and studies that included diet changes and weight loss alongside medication had better outcomes.16ScienceDirect. Evidence-Based Medicine Chronic Cough Due to Gastroesophageal Reflux in Adults: CHEST Guideline and Expert Panel Report
That does not mean PPIs are useless. In open-label studies where patients were selected based on confirmed reflux, about 60 percent reported complete cough relief, and doubling the dose did not improve outcomes beyond the standard dose.17PubMed Central. Proton pump inhibitor treatment of patients with gastroesophageal reflux-related chronic cough: a comparison between two different daily doses of lansoprazole The likely explanation for the discrepancy is patient selection. If reflux is genuinely causing your cough, PPIs can help. But in unselected populations of chronic cough patients, many will not have reflux as the primary driver, and giving everyone a PPI blurs the signal.
Lifestyle modifications deserve more credit than they typically get. Elevating the head of the bed, avoiding eating within a few hours of lying down, losing weight if relevant, and limiting trigger foods (fatty meals, alcohol, caffeine, chocolate) all reduce the volume and frequency of reflux. The expert panel report noted that cough outcomes were better in studies that combined these changes with medication than in trials of medication alone.18ScienceDirect. Evidence-Based Medicine Chronic Cough Due to Gastroesophageal Reflux in Adults: CHEST Guideline and Expert Panel Report A stepwise approach, starting with lifestyle changes and a PPI trial and reserving more aggressive options for refractory cases, is the recommended strategy.19PubMed Central. Diagnostic and Management Approach to Reflux-Related Cough
Neuromodulators for Stubborn Cases
When cough persists despite adequate acid suppression and lifestyle adjustments, the problem may be a cough reflex that has been wound up for so long that it stays hypersensitive even after the reflux trigger is controlled. This is where neuromodulators come in. Gabapentin and baclofen are the two most studied options. Both work by different routes: baclofen reduces reflux episodes by strengthening the lower esophageal sphincter, while gabapentin appears to dampen the cough reflex itself at the nerve level.
A randomized trial comparing the two found they achieved similar success rates, roughly 55 to 57 percent, and both reduced cough sensitivity to capsaicin. Gabapentin came out ahead in tolerability, with less drowsiness and less dizziness than baclofen.20PubMed. Randomised clinical trial: gabapentin vs baclofen in the treatment of suspected refractory gastro-oesophageal reflux-induced chronic cough Both carry side effects that include sedation and sometimes nausea, so they are not first-line treatments, but for patients who have exhausted other options, they offer a meaningful chance of relief.21PubMed Central. Gabapentin versus baclofen for treatment of refractory gastroesophageal reflux-induced chronic cough
When Surgery Becomes an Option
Anti-reflux surgery, typically a laparoscopic Nissen fundoplication, wraps the top of the stomach around the lower esophagus to physically prevent reflux. It addresses both acid and non-acid reflux, which is why it can succeed where PPIs fail. In a long-term follow-up study, about 78 percent of chronic cough patients who underwent the procedure reported relief from cough at a mean follow-up of roughly four years. About a fifth saw symptoms recur, on average within a year.22PubMed Central. Long-Term Outcomes of Chronic Cough Reduction after Laparoscopic Nissen Fundoplication—A Single-Center Study
Surgery is not offered casually. Clinicians typically reserve it for patients who have confirmed reflux-cough association on objective testing and who either cannot tolerate or have failed medical therapy. The patients in the non-acid reflux study who underwent fundoplication stopped all acid-suppressive medication and remained cough-free over more than a year of follow-up.23Chest. Nonacid reflux in patients with chronic cough on acid-suppressive therapy For the right patient, it can be a definitive solution, but the selection process matters enormously. Patients without objective evidence of reflux-cough correlation tend not to benefit from surgery any more than they benefit from PPIs.
Overlapping Causes and the Pathogenic Triad
One of the most common traps in diagnosing reflux cough is assuming only one condition can be responsible. In practice, chronic cough frequently has more than one cause operating simultaneously. A study analyzing cases of chronic cough found that asthma, upper-airway cough syndrome, and reflux, alone or in combination, accounted for over 93 percent of cases.24PubMed. A pathogenic triad in chronic cough: asthma, postnasal drip syndrome, and gastroesophageal reflux disease The overlap means that treating only one contributing factor may produce partial improvement but leave the cough frustratingly persistent.
The interplay between these conditions also complicates interpretation of treatment trials. If a patient’s cough is 60 percent driven by reflux and 40 percent by asthma, even perfect reflux control will not eliminate the cough. This overlap likely contributes to the underwhelming results of PPI trials in unselected chronic cough populations. A clinician who works through each potential contributor and addresses them in parallel is more likely to get you to resolution than one who tests a single therapy and moves on when it falls short.
Reflux Cough in Children
Children can develop reflux-related cough, but the diagnostic and treatment approach differs from adults. An expert panel report on pediatric chronic cough and gastroesophageal reflux concluded that anti-reflux treatments should not be prescribed when there are no clinical features of reflux disease, and that pediatric-specific guidelines should drive both testing and treatment decisions.25PubMed Central. Chronic Cough and Gastroesophageal Reflux in Children: CHEST Guideline and Expert Panel Report The concern is that PPIs are sometimes prescribed reflexively for children with unexplained cough, even without evidence of reflux, and the medications carry risks of their own in pediatric populations. If your child has a chronic cough, the question to push on with their doctor is whether there are actual signs of reflux disease rather than simply accepting an empirical PPI trial.
The Emerging Role of the Microbiome
An active area of research is whether reflux changes the community of bacteria living in the throat and airways, and whether those changes contribute to symptoms. Patients with laryngopharyngeal reflux have been found to harbor a significantly different bacterial profile in their throat compared to healthy people.26PubMed. Distinct microbiota dysbiosis in patients with laryngopharynx reflux disease compared to healthy controls A hypothesis paper has proposed that the mix of enzymes in refluxate, not just acid but also pepsin and bile, may alter the throat’s bacterial ecosystem in ways that impair the mucosa’s ability to heal and recover.27Medical Hypotheses. Laryngopharyngeal reflux: The microbiota theory
In children with chronic cough, researchers have found differences in the bacterial communities of the upper and lower airways depending on the underlying diagnosis, and greater mismatch between upper and lower airway bacteria was linked to more neutrophilic airway inflammation.28PubMed. Aerodigestive dysbiosis in children with chronic cough None of this research has led to a treatment yet. But it suggests that the damage reflux does to the throat and airways is not simply about chemical burns from acid. The bacterial environment may be part of the story, and future therapies could potentially target it.